{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T05:05:03Z","timestamp":1794891903530,"version":"4.9.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T00:00:00Z","timestamp":1747785600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T00:00:00Z","timestamp":1747785600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Malaria is endemic in Mozambique and one of the leading causes of death in children under 5 years old. In 2020 the country adopted the WHO-recommended seasonal malaria chemoprevention (SMC) strategy and delivered the intervention in all 23 districts of Nampula province between January and April 2023. The aim of this study is to estimate the cost-effectiveness of SMC in Nampula, Mozambique.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Financial cost of implementing SMC were estimated from a limited health care provider perspective for the year 2023 in US$. Data on resource use of the SMC implementation was assessed from Malaria Consortium records. The number of eligible and treated children was collected from surveys after cycle 4. The number of malaria cases, deaths and Disability Adjusted Life-Years (DALYs) averted were estimated based on data from Global Burden of Disease 2019, Malaria Indicator Survey 2018, and National Malaria Control Programme. Incremental cost-effectiveness ratios (ICERs) were estimated, and sensitivity analyses were used to test the robustness of the ICERs.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The total financial cost of SMC implementation in Nampula province in 2023 was estimated to be $7,871,361.72. The study estimated a cost per targeted child of $6.05 and a cost per child who received full 3-day course of sulfadoxine-pyrimethamine in combination with amodiaquine (SPAQ) of $7.92. Furthermore, the cost per household with eligible children visited by a community distributor was $7.65; the cost per child who received day 1 SPAQ was $7.85 and the cost per child who received day 1 SPAQ by community distributor adhering to directly observed treatment was $8.50. In addition, the estimated cost was $93.50 per malaria case averted, $3286.59 per malaria death averted, and $130.16 per DALY averted. The ICERs were robust to a variety of alternative assumptions on costs and benefit estimates. Finally, $1,726,189.63 could have been saved if no ineligible children (60\u2013119\u00a0months old) were treated through the programme.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>In line with existing evidence from other African countries, SMC is found to be cost-effective in Mozambique. SMC is a beneficial prevention strategy to improve under-five health in the country, at a relatively low-cost.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12936-025-05401-x","type":"journal-article","created":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T16:38:25Z","timestamp":1747845505000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Seasonal malaria chemoprevention in northern Mozambique: a cost-effectiveness analysis"],"prefix":"10.1186","volume":"24","author":[{"given":"Neide","family":"Canana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan Alejandro Pulido","family":"Tarquino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00f3nia","family":"Enosse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Rassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akashdeep Singh","family":"Chauhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuks","family":"Nnaji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baltazar","family":"Candrinho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa M.","family":"Maffioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,21]]},"reference":[{"key":"5401_CR1","volume-title":"World malaria report 2023","author":"WHO","year":"2023","unstructured":"WHO. World malaria report 2023. Geneva: World Health Organization; 2023."},{"key":"5401_CR2","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1186\/s12936-016-1470-8","volume":"15","author":"D Moonasar","year":"2016","unstructured":"Moonasar D, Maharaj R, Kunene S, Candrinho B, Saute F, Ntshalintshali N, Morris N. Towards malaria elimination in the MOSASWA (Mozambique, South Africa and Swaziland) region. Malar J. 2016;15:419.","journal-title":"Malar J"},{"key":"5401_CR3","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1186\/s12936-019-2832-9","volume":"18","author":"P Aide","year":"2019","unstructured":"Aide P, Candrinho B, Galatas B, Munguambe K, Guinovart C, Luis F, et al. Setting the scene and generating evidence for malaria elimination in Southern Mozambique. Malar J. 2019;18:190.","journal-title":"Malar J"},{"key":"5401_CR4","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1086\/505431","volume":"194","author":"E Macete","year":"2006","unstructured":"Macete E, Aide P, Aponte JJ, Sanz S, Mandomando I, Espasa M, et al. Intermittent preventive treatment for malaria control administered at the time of routine vaccinations in Mozambican infants: a randomized, placebo-controlled trial. J Infect Dis. 2006;194:276\u201385.","journal-title":"J Infect Dis"},{"key":"5401_CR5","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1038\/ncomms1879","volume":"3","author":"M Cairns","year":"2012","unstructured":"Cairns M, Roca-Feltrer A, Garske T, Wilson AL, Diallo D, Milligan PJ, et al. Estimating the potential public health impact of seasonal malaria chemoprevention in African children. Nat Commun. 2012;3:881.","journal-title":"Nat Commun"},{"key":"5401_CR6","volume-title":"Seasonal malaria chemoprevention with sulfadoxine\u2013pyrimethamine plus amodiaquine in children: a field guide","author":"WHO","year":"2023","unstructured":"WHO. Seasonal malaria chemoprevention with sulfadoxine\u2013pyrimethamine plus amodiaquine in children: a field guide. Geneva: World Health Organization; 2023."},{"key":"5401_CR7","volume-title":"Policy Recommendation: Seasonal Malaria Chemoprevention (SMC) for Plasmodium falciparum malaria control in highly seasonal transmission areas of the Sahel sub-region in Africa","author":"WHO","year":"2012","unstructured":"WHO. Policy Recommendation: Seasonal Malaria Chemoprevention (SMC) for Plasmodium falciparum malaria control in highly seasonal transmission areas of the Sahel sub-region in Africa. Geneva: World Health Organization; 2012."},{"key":"5401_CR8","volume-title":"Guidelines for malaria","author":"WHO","year":"2023","unstructured":"WHO. Guidelines for malaria. Geneva: World Health Organization; 2023."},{"key":"5401_CR9","doi-asserted-by":"publisher","DOI":"10.2196\/27855","volume":"10","author":"A Wharton-Smith","year":"2021","unstructured":"Wharton-Smith A, Baker K, Roca-Feltrer A, Rodrigues M, Richardson S, Bonnington CA, et al. Assessment of the feasibility, acceptability, and impact of implementing seasonal malaria chemoprevention in Nampula Province, Mozambique: protocol for a hybrid effectiveness-implementation study. JMIR Res Protoc. 2021;10: e27855.","journal-title":"JMIR Res Protoc"},{"key":"5401_CR10","doi-asserted-by":"publisher","DOI":"10.7189\/jogh.07.010402","volume":"7","author":"T Guenther","year":"2017","unstructured":"Guenther T, Sadruddin S, Finnegan K, Wetzler E, Ibo F, Rapaz P, et al. Contribution of community health workers to improving access to timely and appropriate case management of childhood fever in Mozambique. J Glob Health. 2017;7: 010402.","journal-title":"J Glob Health"},{"key":"5401_CR11","doi-asserted-by":"publisher","DOI":"10.2196\/36403","volume":"11","author":"K Baker","year":"2022","unstructured":"Baker K, Aide P, Bonnington CA, Rassi C, Richardson S, Roca-Feltrer A, et al. Feasibility, acceptability, and protective efficacy of seasonal malaria chemoprevention implementation in Nampula province, Mozambique: protocol for a hybrid effectiveness-implementation study. JMIR Res Protoc. 2022;11: e36403.","journal-title":"JMIR Res Protoc"},{"key":"5401_CR12","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1016\/S0140-6736(20)32227-3","volume":"396","author":"E Baba","year":"2020","unstructured":"Baba E, Hamade P, Kivumbi H, Marasciulo M, Maxwell K, Moroso D, et al. Effectiveness of seasonal malaria chemoprevention at scale in West and Central Africa: an observational study. Lancet. 2020;396:1829\u201340.","journal-title":"Lancet"},{"key":"5401_CR13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003727","volume":"18","author":"M Cairns","year":"2021","unstructured":"Cairns M, Ceesay SJ, Sagara I, Zongo I, Kessely H, Gamougam K, et al. Effectiveness of seasonal malaria chemoprevention (SMC) treatments when SMC is implemented at scale: case\u2013control studies in 5 countries. PLoS Med. 2021;18: e1003727.","journal-title":"PLoS Med"},{"key":"5401_CR14","doi-asserted-by":"publisher","first-page":"e199","DOI":"10.1016\/S2214-109X(20)30475-7","volume":"9","author":"C Gilmartin","year":"2021","unstructured":"Gilmartin C, Nonvignon J, Cairns M, Milligan P, Bocoum F, Winskill P, et al. Seasonal malaria chemoprevention in the Sahel subregion of Africa: a cost-effectiveness and cost-savings analysis. Lancet Glob Health. 2021;9:e199-208.","journal-title":"Lancet Glob Health"},{"key":"5401_CR15","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s12936-023-04488-4","volume":"22","author":"A Nuwa","year":"2023","unstructured":"Nuwa A, Baker K, Bonnington C, Odongo M, Kyagulanyi T, Bwanika JB, et al. A non-randomized controlled trial to assess the protective effect of SMC in the context of high parasite resistance in Uganda. Malar J. 2023;22:63.","journal-title":"Malar J"},{"key":"5401_CR16","first-page":"33","volume":"23","author":"J Khan","year":"2024","unstructured":"Khan J, Suau Sans M, Okot F, Rom Ayuiel A, Magoola J, Rassi C, et al. A quasi-experimental study to estimate effectiveness of seasonal malaria chemoprevention in Aweil South County in Northern Bahr El Ghazal. South Sudan Malar J. 2024;23:33.","journal-title":"South Sudan Malar J"},{"key":"5401_CR17","doi-asserted-by":"publisher","first-page":"e478","DOI":"10.1016\/S2214-109X(23)00550-8","volume":"12","author":"L Braunack-Mayer","year":"2024","unstructured":"Braunack-Mayer L, Malinga J, Masserey T, Nekkab N, Sen S, Schellenberg D, et al. Design and selection of drug properties to increase the public health impact of next-generation seasonal malaria chemoprevention: a modelling study. Lancet Glob Health. 2024;12:e478\u201390.","journal-title":"Lancet Glob Health"},{"key":"5401_CR18","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s12936-024-04916-z","volume":"23","author":"T Ibinaiye","year":"2024","unstructured":"Ibinaiye T, Rotimi K, Balogun A, Aidenagbon A, Oguoma C, Rassi C, et al. Receipt of seasonal malaria chemoprevention by age-ineligible children and associated factors in nine implementation states in Nigeria. Malar J. 2024;23:91.","journal-title":"Malar J"},{"key":"5401_CR19","volume-title":"Quantitative report on seasonal malaria chemoprevention supported by Malaria Consortium in 2021: coverage and quality in Burkina Faso, Chad, Nigeria, and Togo","author":"Malaria Consortium","year":"2022","unstructured":"Malaria Consortium. Quantitative report on seasonal malaria chemoprevention supported by Malaria Consortium in 2021: coverage and quality in Burkina Faso, Chad, Nigeria, and Togo. London: Malaria Consortium; 2022."},{"key":"5401_CR20","unstructured":"Malaria Consortium. Coverage and quality of seasonal malaria chemoprevention supported by Malaria Consortium in 2022: Results from Burkina Faso, Chad, Mozambique, Nigeria, South Sudan, Togo and Uganda. April 2023"},{"key":"5401_CR21","unstructured":"Malaria Consortium. 2022\u20132023 SMC Campaign in Mozambique: Final Report. November 2023."},{"key":"5401_CR22","unstructured":"Malaria Consortium. Coverage and quality of seasonal malaria chemoprevention supported by Malaria Consortium with philanthropic funding or co-funding in 2023: Results from Burkina Faso, Chad, Mozambique, Nigeria, South Sudan, Togo and Uganda. April 2024."},{"key":"5401_CR23","doi-asserted-by":"publisher","DOI":"10.9745\/GHSP-D-21-00161","volume":"10","author":"A Mouk\u00e9net","year":"2022","unstructured":"Mouk\u00e9net A, Donovan L, Honor\u00e9 B, Baker K, Smith H, Richardson S, Ward C. Extending delivery of seasonal malaria chemoprevention to children aged 5\u201310 years in Chad: a mixed-methods study. Glob Health Sci Pract. 2022;10: e2100161.","journal-title":"Glob Health Sci Pract"},{"key":"5401_CR24","unstructured":"Global Burden of Disease Study (GBD) 2019. https:\/\/www.healthdata.org\/research-analysis\/gbd."},{"key":"5401_CR25","unstructured":"Malaria Indicator Survey (MIS). 2018. The Demographic Health Survey. Mozambique. https:\/\/dhsprogram.com\/methodology\/survey\/survey-display-527.cfm."},{"key":"5401_CR26","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1186\/s12936-019-2995-4","volume":"18","author":"S Alonso","year":"2019","unstructured":"Alonso S, Chaccour CJ, Elobolobo E, Nacima A, Candrinho B, Saifodine A, et al. The economic burden of malaria on households and the health system in a high transmission district of Mozambique. Malar J. 2019;18:360.","journal-title":"Malar J"},{"key":"5401_CR27","unstructured":"Candrinho B. Seasonal malaria chemoprevention: results from Mozambique implementation study 2020\u20132021. Presented at Annual Meeting of the American Society of Tropical Medicine & Hygiene 2021. Malaria Consortium. https:\/\/files.givewell.org\/files\/DWDA%202009\/Malaria%20Consortium\/Candrinho_2021.pdf"},{"key":"5401_CR28","unstructured":"Candrinho B. Seasonal malaria chemoprevention: results from Mozambique implementation study 2020\u20132022. Presented at Annual Meeting of the American Society of Tropical Medicine & Hygiene 2022. Malaria Consortium. https:\/\/www.malariaconsortium.org\/gallery-file\/12010557-90\/astmh2022drbcandrinho2.pdf"},{"key":"5401_CR29","unstructured":"GiveWell. 2023. Cost-Effectiveness Analysis of Seasonal Chemo Prevention. Available at https:\/\/docs.google.com\/spreadsheets\/d\/1fUZFe-pDvRqXdZVnyvCUdKYs7BgX9S7a5qBEVwwqrzQ\/edit#gid=175487621"},{"key":"5401_CR30","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s12936-020-03175-y","volume":"19","author":"D Issiaka","year":"2020","unstructured":"Issiaka D, Barry A, Traore T, Diarra B, Cook D, Keita M, et al. Impact of seasonal malaria chemoprevention on hospital admissions and mortality in children under 5 years of age in Ouelessebougou. Mali Malar J. 2020;19:103.","journal-title":"Mali Malar J"},{"key":"5401_CR31","volume":"2012","author":"MM Meremikwu","year":"2012","unstructured":"Meremikwu MM, Donegan S, Sinclair D, Esu E, Oringanje C. Intermittent preventive treatment for malaria in children living in areas with seasonal transmission. Cochrane Database Syst Rev. 2012;2012: CD003756.","journal-title":"Cochrane Database Syst Rev"},{"key":"5401_CR32","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1111\/tmi.12642","volume":"21","author":"H Tagbor","year":"2016","unstructured":"Tagbor H, Antwi GD, Acheampong PR, Bart Plange C, Chandramohan D, Cairns M. Seasonal malaria chemoprevention in an area of extended seasonal transmission in Ashanti, Ghana: an individually randomised clinical trial. Trop Med Int Health. 2016;21:224\u201335.","journal-title":"Trop Med Int Health"},{"key":"5401_CR33","unstructured":"Milligan P, Lal S, Cairns M, Scott S, Diallo A, NDiaye JL et al. Assessment of the impact of ACCESS-SMC on malaria cases and deaths in 2015 and 2016; Report for UNITAID, LSHTM. 2018."},{"key":"5401_CR34","unstructured":"Cairns M, Sagara I, Zongo I, Ceesay S, Kesseley H, Eloike T et al. Assessment of the protective effect of Seasonal Malaria Chemoprevention with sulfadoxine-pyrimethamine plus amodiaquine in Burkina Faso, Chad, The Gambia, Mali and Nigeria, 2015\u20132016; Report for UNITAID, LSHTM 2018."},{"key":"5401_CR35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0016976","volume":"6","author":"AL Wilson","year":"2011","unstructured":"Wilson AL, IPTc Taskforce. A systematic review and meta-analysis of the efficacy and safety of intermittent preventive treatment of malaria in children (IPTc). PLoS ONE. 2011;6: e16976.","journal-title":"PLoS ONE"},{"key":"5401_CR36","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s12936-020-03191-y","volume":"19","author":"A Bicaba","year":"2020","unstructured":"Bicaba A, Serme L, Chetaille G, Kombate G, Bila A, Haddad S. Longitudinal analysis of the capacities of community health workers mobilized for seasonal malaria chemoprevention in Burkina Faso. Malar J. 2020;19:118.","journal-title":"Malar J"},{"key":"5401_CR37","doi-asserted-by":"publisher","first-page":"8104","DOI":"10.1038\/s41598-018-26474-6","volume":"8","author":"T Druetz","year":"2018","unstructured":"Druetz T. Evaluation of direct and indirect effects of seasonal malaria chemoprevention in Mali. Sci Rep. 2018;8:8104.","journal-title":"Sci Rep"},{"key":"5401_CR38","doi-asserted-by":"publisher","first-page":"524","DOI":"10.4269\/ajtmh.17-0599","volume":"98","author":"T Druetz","year":"2017","unstructured":"Druetz T, Corneau-Tremblay N, Millogo T, Kouanda S, Ly A, Bicaba A, et al. Impact evaluation of seasonal malaria chemoprevention under routine program implementation: a quasi-experimental study in Burkina Faso. Am J Trop Med Hyg. 2017;98:524\u201333.","journal-title":"Am J Trop Med Hyg"},{"key":"5401_CR39","doi-asserted-by":"publisher","first-page":"411","DOI":"10.4269\/ajtmh.2007.77.411","volume":"77","author":"B Ntab","year":"2007","unstructured":"Ntab B, Ciss\u00e9 B, Boulanger D, Sokhna C, Targett G, Lines J, et al. Impact of intermittent preventive anti-malarial treatment on the growth and nutritional status of preschool children in rural Senegal (West Africa). Am J Trop Med Hyg. 2007;77:411\u20137.","journal-title":"Am J Trop Med Hyg"},{"key":"5401_CR40","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.4269\/ajtmh.21-0314","volume":"105","author":"S Richardson","year":"2021","unstructured":"Richardson S, Moukenet A, Diar MS, de Cola MA, Rassi C, Counihan H, et al. Modeled impact of seasonal malaria chemoprevention on district-level suspected and confirmed malaria cases in Chad based on routine clinical data (2013\u20132018). Am J Trop Med Hyg. 2021;105:1712\u201321.","journal-title":"Am J Trop Med Hyg"},{"key":"5401_CR41","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s12936-018-2242-4","volume":"17","author":"RF Grais","year":"2018","unstructured":"Grais RF, Laminou IM, Woi-Messe L, Makarimi R, Bouriema SH, Langendorf C, et al. Molecular markers of resistance to amodiaquine plus sulfadoxine\u2013pyrimethamine in an area with seasonal malaria chemoprevention in south central Niger. Malar J. 2018;17:98.","journal-title":"Malar J"},{"key":"5401_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/trstmh\/trx012","volume":"111","author":"B Greenwood","year":"2017","unstructured":"Greenwood B. Elimination of malaria: halfway there. Trans R Soc Trop Med Hyg. 2017;111:1\u20132.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"5401_CR43","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1093\/cid\/civ881","volume":"62","author":"M Desai","year":"2016","unstructured":"Desai M, Gutman J, Taylor SM, Wiegand RE, Khairallah C, Kayentao K, et al. Impact of sulfadoxine-pyrimethamine resistance on effectiveness of intermittent preventive therapy for malaria in pregnancy at clearing infections and preventing low birth weight. Clin Infect Dis. 2016;62:323\u201333.","journal-title":"Clin Infect Dis"},{"key":"5401_CR44","doi-asserted-by":"publisher","first-page":"7389","DOI":"10.1038\/s41598-017-06708-9","volume":"7","author":"LC Okell","year":"2017","unstructured":"Okell LC, Griffin JT, Roper C. Mapping sulphadoxine-pyrimethamine-resistant Plasmodium falciparum malaria in infected humans and in parasite populations in Africa. Sci Rep. 2017;7:7389.","journal-title":"Sci Rep"},{"key":"5401_CR45","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1186\/s12936-017-2132-1","volume":"16","author":"ME Coldiron","year":"2017","unstructured":"Coldiron ME, von Seidlein L, Grais RF. Seasonal malaria chemoprevention: successes and missed opportunities. Malar J. 2017;16:481.","journal-title":"Malar J"},{"key":"5401_CR46","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1186\/s12936-023-04740-x","volume":"22","author":"I Molina-De la Fuente","year":"2023","unstructured":"Molina-De la Fuente I, Sagrado Benito MJ, Lasry E, Ousley J, Garc\u00eda L, Gonz\u00e1lez V, et al. Seasonal malaria chemoprevention in a context of high presumed sulfadoxine-pyrimethamine resistance: malaria morbidity and molecular drug resistance profiles in South Sudan. Malar J. 2023;22:345.","journal-title":"Malar J"},{"key":"5401_CR47","first-page":"240","volume":"8","author":"Y Togo","year":"2023","unstructured":"Togo Y, Sangho O, Tour\u00e9 M, Marker H, Kayentao K, McGovern M, et al. What to know about the cost-effectiveness of seasonal malaria chemoprevention in endemic countries: a systematic review. Int J Innov Sci Res Technol. 2023;8:240\u20137.","journal-title":"Int J Innov Sci Res Technol"},{"key":"5401_CR48","doi-asserted-by":"publisher","first-page":"123","DOI":"10.2471\/BLT.08.051961","volume":"87","author":"G Hutton","year":"2009","unstructured":"Hutton G, Schellenberg D, Tediosi F, Macete E, Kahigwa E, Sigauque B, et al. Cost-effectiveness of malaria intermittent preventive treatment in infants (IPTi) in Mozambique and the United Republic of Tanzania. Bull World Health Organ. 2009;87:123\u20139.","journal-title":"Bull World Health Organ"},{"key":"5401_CR49","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/s12936-021-03653-x","volume":"20","author":"H Diawara","year":"2021","unstructured":"Diawara H, Walker P, Cairns M, Steinhardt LC, Diawara F, Kamate B, et al. Cost-effectiveness of district-wide seasonal malaria chemoprevention when implemented through routine malaria control programme in Kita, Mali using fixed point distribution. Malar J. 2021;20:128.","journal-title":"Malar J"},{"key":"5401_CR50","doi-asserted-by":"publisher","first-page":"A88","DOI":"10.1016\/j.jval.2015.03.517","volume":"18","author":"M Griffiths","year":"2015","unstructured":"Griffiths M, Maruszczak M, Kusel J. The who-choice cost-effectiveness threshold: a country-level analysis of changes over time. Value Health. 2015;18:A88.","journal-title":"Value Health"},{"key":"5401_CR51","unstructured":"World Bank. 2022. https:\/\/data.worldbank.org\/indicator\/NY.GDP.PCAP.CD?locations=MZ"},{"key":"5401_CR52","doi-asserted-by":"publisher","first-page":"811","DOI":"10.4269\/ajtmh.19-0600","volume":"102","author":"J Thwing","year":"2019","unstructured":"Thwing J, Camara A, Candrinho B, Zulliger R, Colborn J, Painter J, et al. A robust estimator of malaria incidence from routine health facility data. Am J Trop Med Hyg. 2019;102:811\u201320.","journal-title":"Am J Trop Med Hyg"}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-025-05401-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12936-025-05401-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-025-05401-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T18:02:51Z","timestamp":1747850571000},"score":1,"resource":{"primary":{"URL":"https:\/\/malariajournal.biomedcentral.com\/articles\/10.1186\/s12936-025-05401-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,21]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5401"],"URL":"https:\/\/doi.org\/10.1186\/s12936-025-05401-x","relation":{},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,21]]},"assertion":[{"value":"27 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study has been approved by National Ethical Review Board, Comit\u00e9 Nacional de Bio\u00e9tica para a Sa\u00fade (CNBS). IRB 00002657. Protocol approved Ref: 589\/CNBS\/23.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"159"}}